UCB9741
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for UCB9741, covering 2025-11-28 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis [Phase 1, Phase 2]